Metric Finance
LearnFAQ
LearnFAQ

Learn / ALMR

NASDAQ: ALMR

Alamar Biosciences (ALMR) stock, explained like you're 5

Alamar Biosciences trades on the Nasdaq under the ticker ALMR. It is a small cap company in the laboratory analytical instruments industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.

Ticker
ALMR
Exchange
Nasdaq
Sector
Healthcare
Industry
Laboratory Analytical Instruments
Size
Small cap, about 1.8 billion dollars

Is Alamar Biosciences a small, medium or large cap company?

No. Alamar Biosciences is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.8 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Alamar Biosciences makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves ALMR stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • An affiliate proposes selling 41,945 Alamar Biosciences (ALMR) shares through J.P. Morgan Securities LLC. (Stock Titan)
  • Alamar Biosciences, Inc. (ALMR) stock price, news, quote and history (Yahoo Finance Australia)
  • Certain Class B Common Stock of Alamar Biosciences, Inc. are subject to a Lock Up Agreement Ending on 14 OCT 2026. (www.marketscreener.com)
  • Form 144 Alamar Biosciences For: 14 October By Investing.com (Investing.com Nigeria)
  • symbol__ Stock Quote Price and Forecast (CNN)

Follow ALMR in your daily brief

Each trading day at 5 PM ET we post what happened to Alamar Biosciences and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow ALMR

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Alamar Biosciences stock

What does Alamar Biosciences do?

Alamar Biosciences trades on the Nasdaq under the ticker ALMR. It is a small cap company in the laboratory analytical instruments industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.

What is the ticker symbol for Alamar Biosciences?

Alamar Biosciences trades under the ticker ALMR on the Nasdaq.

What is Alamar Biosciences's market cap?

Alamar Biosciences is a small cap stock with a market cap of about 1.8 billion dollars.

How does Alamar Biosciences make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves ALMR stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow ALMR stock every day?

Add ALMR to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow ALMR daily

A free brief on Alamar Biosciences and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • BRKRP · Bruker
  • A · Agilent Technologies
  • WAT · Waters Corp /De/
  • MTD · Mettler Toledo International Inc/

Similar stocks

  • BRKRPBruker
  • AAgilent Technologies
  • WATWaters Corp /De/
  • MTDMettler Toledo International Inc/

Compare ALMR: ALMR vs BRKRP, ALMR vs A, ALMR vs WAT

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed